IN BRIEF: Bayer buys camelina assets from Smart Earth Camelina

9th January 2025 18:00

Bayer AG - Leverkusen, Germany-based pharmaceutical and biotechnology company - Acquires camelina germplasm and intellectual property assets from Smart Earth Camelina Corp. Explains the deal will help meet growing demand for renewable fuel. The addition of camelina crops to Bayer’s portfolio expands its leadership position in biomass-based feedstock while providing growers with an additional revenue stream, Bayer says.

Camelina is a novel intermediate oilseed crop with a promising low-carbon intensity for renewable fuel and can be grown in both spring and winter. Bayer intends to use its expertise in oilseeds to further develop this product.

No financial details were disclosed.

Current stock price: EUR19.76

12-month change: down 45%

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Get more news and expert articles direct to your inbox